Annual Gianaris Pancreatic Cancer Symposium is Nov. 16
Wednesday, November 8, 2017
Faculty and physicians are invited to attend the annual Andrea Gianaris Pancreatic Cancer Symposium.
The half-day symposium is 8 a.m. to 12:30 p.m. Thursday, Nov. 16 in Walther Hall, Room 203, 980 W. Walnut St. Parking is available in the Lockfield Garage, 951 Wishard Blvd. (Exit the southwest side of the garage on foot for access to Walnut Street and Walther Hall.)
The symposium features the leading pancreatic surgeon in the country, Keith Lillemoe, M.D., chief of surgery at Massachusetts General and the Harvard Medical School. He previously led the Department of Surgery at IU School of Medicine. Gabriela Chiorean, M.D., is also returning to IU to present oncology advancements in the treatment of pancreatic cancer and the science driving new therapies. Dr. Chiorean is now a medical oncologist specializing in pancreatic cancer at Fred Hutchinson Cancer Research Center in Seattle.
The symposium also features a panel of IU pancreatic specialists who will discuss case studies and interact with attendees.
IU School of Medicine faculty generated $1.13 million in pancreatic cancer research funding in 2016 from the National Cancer Institute. They perform 3,000 pancreatic procedures annually, host the only high-risk clinic in the country, and nationally are ranked #1 in diagnostic procedures and #2 in the number of surgeries for pancreatic cancer annually.
Dr. Peter Gianaris, a neurosurgeon with Goodman Campbell Brain and Spine, established the symposium in memory of his wife, Andrea, in 2011.
Registration is required to attend this free symposium. The symposium provides 3.5 CME credit hours.
Questions? Call (317) 274-7409.
8 a.m.: Registration and continental breakfast
8:45 a.m.: Welcoming remarks
9 a.m.: Session I: Keith D. Lillemoe, M.D.
“Pancreatic Cancer: Current Management and Outcomes. Is There Hope on the Horizon?”
- Recognize the value of the multidisciplinary management of pancreatic cancer
- Identify the precursors of pancreatic cancer
- Identify the progress in the surgical management of pancreatic cancer, including new technology
- Recognize the evolving paradigm for treatment locally advanced pancreatic cancer
“Pancreatic Cancer — Updates in Translational Research”
- Identify relevant signaling pathways and molecular profiles in pancreatic cancer
- Recognize key targets for therapeutic targeting
- Recall contemporary clinical trials with molecularly targeted therapeutics in pancreatic cancer
11 a.m.: Lunch and panel discussion
Moderator: Michael G. House, M.D.
Panelist: Drs. Chiorean, Cummings, Ellsworth, Lillemoe, O’Neil, Sherman
12:30 p.m.: Closing remarks